Aqr Capital Management LLC Exelixis, Inc. Transaction History

Aqr Capital Management LLC

  • $151 Billion
  • Q3 2025

A detailed history of Aqr Capital Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 9,181,359 shares of EXEL stock, worth $382 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
9,181,359
Previous 7,606,079 20.71%
Holding current value
$382 Million
Previous $335 Million 13.1%
% of portfolio
0.25%
Previous 0.29%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$36.22 - $46.25 $57.1 Million - $72.9 Million
1,575,280 Added 20.71%
9,181,359 $379 Million
Q2 2025

Aug 14, 2025
BUY
$34.13 - $46.26 $24.3 Million - $32.9 Million
712,190 Added 10.33%
7,606,079 $335 Million
Q1 2025

May 15, 2025
BUY
$32.38 - $39.16 $94.8 Million - $115 Million
2,926,884 Added 73.78%
6,893,889 $255 Million
Q4 2024

Feb 14, 2025
BUY
$25.39 - $36.46 $20.6 Million - $29.6 Million
810,857 Added 25.69%
3,967,005 $132 Million
Q3 2024

Nov 14, 2024
SELL
$21.96 - $27.6 $2.75 Million - $3.46 Million
-125,430 Reduced 3.82%
3,156,148 $81.9 Million
Q2 2024

Aug 14, 2024
BUY
$20.34 - $23.73 $7.53 Million - $8.78 Million
370,199 Added 12.72%
3,281,578 $73.7 Million
Q1 2024

May 15, 2024
BUY
$20.17 - $23.93 $14.8 Million - $17.5 Million
732,674 Added 33.63%
2,911,379 $69.1 Million
Q4 2023

Feb 14, 2024
BUY
$19.25 - $24.13 $3.14 Million - $3.93 Million
162,867 Added 8.08%
2,178,705 $52.3 Million
Q3 2023

Nov 14, 2023
BUY
$19.04 - $22.74 $2.18 Million - $2.6 Million
114,267 Added 6.01%
2,015,838 $44 Million
Q2 2023

Aug 14, 2023
SELL
$18.17 - $20.48 $7.92 Million - $8.93 Million
-435,829 Reduced 18.65%
1,901,571 $36.3 Million
Q1 2023

May 15, 2023
SELL
$16.3 - $19.41 $4.71 Million - $5.61 Million
-289,203 Reduced 11.01%
2,337,400 $45.4 Million
Q4 2022

Feb 14, 2023
BUY
$14.96 - $17.39 $13.8 Million - $16.1 Million
924,500 Added 54.32%
2,626,603 $42.1 Million
Q3 2022

Nov 14, 2022
SELL
$15.68 - $22.27 $4.12 Million - $5.85 Million
-262,616 Reduced 13.37%
1,702,103 $26.7 Million
Q2 2022

Aug 15, 2022
BUY
$17.44 - $23.16 $19 Million - $25.2 Million
1,089,169 Added 124.4%
1,964,719 $40.5 Million
Q1 2022

May 16, 2022
BUY
$17.03 - $22.67 $6.85 Million - $9.12 Million
402,127 Added 84.94%
875,550 $19.7 Million
Q4 2021

Feb 14, 2022
BUY
$15.84 - $21.88 $2.85 Million - $3.93 Million
179,734 Added 61.2%
473,423 $8.65 Million
Q3 2021

Nov 15, 2021
BUY
$16.3 - $21.14 $2.56 Million - $3.32 Million
156,822 Added 114.58%
293,689 $6.18 Million
Q2 2021

Aug 16, 2021
SELL
$17.95 - $25.56 $4.02 Million - $5.72 Million
-223,911 Reduced 62.06%
136,867 $2.46 Million
Q1 2021

May 17, 2021
SELL
$20.53 - $25.22 $18.5 Million - $22.7 Million
-899,201 Reduced 71.37%
360,778 $8.13 Million
Q4 2020

Feb 16, 2021
SELL
$18.39 - $24.8 $17.3 Million - $23.3 Million
-938,169 Reduced 42.68%
1,259,979 $24.9 Million
Q3 2020

Nov 16, 2020
SELL
$20.67 - $26.94 $28.6 Million - $37.3 Million
-1,384,151 Reduced 38.64%
2,198,148 $53.7 Million
Q2 2020

Aug 17, 2020
SELL
$16.46 - $27.42 $32.5 Million - $54.2 Million
-1,975,705 Reduced 35.55%
3,582,299 $82.7 Million
Q1 2020

May 15, 2020
SELL
$14.46 - $21.8 $29.6 Million - $44.6 Million
-2,047,034 Reduced 26.92%
5,558,004 $95.7 Million
Q4 2019

Feb 14, 2020
SELL
$15.15 - $18.89 $72.4 Million - $90.3 Million
-4,777,850 Reduced 38.58%
7,605,038 $134 Million
Q3 2019

Nov 14, 2019
SELL
$17.68 - $22.65 $23.2 Million - $29.7 Million
-1,310,066 Reduced 9.57%
12,382,888 $219 Million
Q2 2019

Aug 14, 2019
SELL
$18.93 - $24.75 $40.9 Million - $53.5 Million
-2,159,602 Reduced 13.62%
13,692,954 $293 Million
Q1 2019

May 14, 2019
BUY
$19.6 - $24.76 $98.4 Million - $124 Million
5,021,444 Added 46.36%
15,852,556 $377 Million
Q4 2018

Feb 14, 2019
BUY
$13.65 - $21.8 $107 Million - $172 Million
7,871,625 Added 265.98%
10,831,112 $213 Million
Q3 2018

Nov 15, 2018
SELL
$15.87 - $22.4 $22.9 Million - $32.3 Million
-1,442,420 Reduced 32.77%
2,959,487 $52.4 Million
Q2 2018

Aug 14, 2018
SELL
$18.56 - $22.45 $57 Million - $69 Million
-3,072,697 Reduced 41.11%
4,401,907 $94.7 Million
Q1 2018

May 15, 2018
BUY
$22.15 - $31.89 $3.29 Million - $4.74 Million
148,672 Added 2.03%
7,474,604 $166 Million
Q4 2017

Feb 14, 2018
BUY
$24.23 - $30.93 $31.7 Million - $40.5 Million
1,307,991 Added 21.73%
7,325,932 $223 Million
Q3 2017

Nov 14, 2017
BUY
$23.35 - $29.24 $141 Million - $176 Million
6,017,941
6,017,941 $146 Million

Others Institutions Holding EXEL

# of Institutions
694
Shares Held
257M
Call Options Held
1.5M
Put Options Held
1.71M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $13.4B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email